IP Library Assignment 035431/0240
Patent Assignment
Reel/Frame 035431/0240

Assignment of Assignor's Interest

Recorded: 2015-04-16 Pages: 26
Assignor
NOVARTIS AG
Executed: 2015-03-13
Assignee
ARROWHEAD RESEARCH CORPORATION
225 SOUTH LAKE AVENUE, SUITE 300, PASADENA, CALIFORNIA, 91101
Covered Properties (22)
Modified Small Interfering Rna Molecules and Methods of Use
Patent: 8,138,161 →
Application: 11/664,008 →
Publication: US 2008/0269148
Rnai Inhibition of Alpha-Enac Expression
Patent: 7,718,632 →
Application: 12/140,112 →
Publication: US 2009/0156529
RNAi Inhibition of Alpha-ENaC Expression
Patent: 9,074,212 →
Application: 12/683,146 →
Publication: US 2010/0190714
Rnai Inhibition of Alpha-Enac Expression
Patent: 7,943,592 →
Application: 12/771,470 →
Publication: US 2010/0210513
Rnai Inhibition of Alpha-Enac Expression
Patent: 7,939,508 →
Application: 12/771,518 →
Publication: US 2010/0216971
Rnai Inhibition of Alpha-Enac Expression
Patent: 8,119,612 →
Application: 12/771,566 →
Publication: US 2010/0216972
Rnai Inhibition of Alpha-Enac Expression
Patent: 8,168,606 →
Application: 12/771,614 →
Publication: US 2010/0210514
Organic Compositions to Treat HSF1-Related Diseases
Patent: 8,293,718 →
Application: 12/970,268 →
Publication: US 2011/0166058
Organic Compositions to Treat Beta-Enac-Related Diseases
Patent: 8,344,127 →
Application: 13/090,580 →
Publication: US 2011/0263681
Modified Small Interfering Rna Molecules and Methods of Use
Patent: 8,765,704 →
Application: 13/325,308 →
Organic Compositions to Treat Beta-Enac-Related Diseases
Patent: 8,344,129 →
Application: 13/355,879 →
Publication: US 2012/0122960
Organic Compositions to Treat Beta-Enac-Related Diseases
Patent: 8,344,130 →
Application: 13/355,903 →
Publication: US 2012/0115933
Organic Compositions to Treat Beta-Enac-Related Diseases
Patent: 8,344,131 →
Application: 13/355,930 →
Publication: US 2012/0115934
dsRNA For Treating Viral Infection
Patent: 8,603,995 →
Application: 13/359,129 →
Publication: US 2012/0129913
Organic Compositions to Treat HSF1-Related Diseases
Patent: 8,481,509 →
Application: 13/363,493 →
Publication: US 2012/0129914
Organic Compositions to Treat HSF1-Related Diseases
Patent: 8,623,838 →
Application: 13/363,504 →
Publication: US 2012/0129915
Organic Compositions to Treat Beta-ENaC-Related Diseases
Patent: 8,598,335 →
Application: 13/614,836 →
Publication: US 2013/0012571
Modified Small Interfering Rna Molecules and Methods of Use
Patent: 9,139,833 →
Application: 13/796,606 →
Publication: US 2014/0073683
ORGANIC COMPOSITIONS TO TREAT Beta-ENaC-RELATED DISEASES
Patent: 9,080,175 →
Application: 14/042,924 →
Publication: US 2014/0107179
Organic Compositions to Treat HSF1-Related Diseases
Patent: 9,096,637 →
Application: 14/054,166 →
Publication: US 2014/0039039
dsRNA For Treating Viral Infection
Patent: 9,133,462 →
Application: 14/069,642 →
Publication: US 2014/0057965
Modified Small Interfering Rna Molecules and Methods of Use
Patent: 9,084,808 →
Application: 14/274,127 →
Publication: US 2015/0148402
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 23, 2011
From: WARMUTH, MARKUS; ZHOU, WENLAI; ZHU, PING; HINKLE, GREGORY
To: NOVARTIS AG
Reel/Frame 026007/0734 →
Assignment of Assignor's Interest Oct 16, 2013
From: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
To: NOVARTIS AG
Reel/Frame 031413/0132 →
Assignment of Assignor's Interest Oct 16, 2013
From: CHEN, JINYUN
To: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Reel/Frame 031413/0054 →
Assignment of Assignor's Interest Feb 27, 2015
From: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
To: NOVARTIS AG
Reel/Frame 035054/0131 →
Assignment of Assignor's Interest May 18, 2015
From: DIENER, JOHN L; HICKMAN, EMMA; PULICHINO, ANNE-MARIE
To: NOVARTIS AG
Reel/Frame 035663/0449 →
Assignment of Assignor's Interest May 18, 2015
From: LABOW, MARK ARON; GAITHER, LARRY ALEXANDER; BORAWSKI, JASON
To: NOVARTIS AG
Reel/Frame 035659/0785 →
Assignment of Assignor's Interest May 18, 2015
From: DE FOUGEROLLES, ANTONIN; HINKLE, GREGORY; MILSTEIN, STUART; SPRAGUE, ANDREW
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 035663/0419 →
Assignment of Assignor's Interest May 18, 2015
From: ALNYLAM PHARMACEUTICALS, INC.
To: NOVARTIS AG
Reel/Frame 035663/0463 →
Assignment of Assignor's Interest May 21, 2015
From: HINKLE, GREGORY; KUCHIMANCHI, SATYANARAYANA; MILSTEIN, STUART; ZIMMERMANN, TRACY S.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 035690/0535 →
Assignment of Assignor's Interest May 21, 2015
From: HAN, JANG; HOUGHTON, MICHAEL
To: CHIRON CORPORATION
Reel/Frame 035686/0705 →
Change of Name May 21, 2015
From: CHIRON CORPORATION
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 035686/0759 →
Assignment of Assignor's Interest May 21, 2015
From: WARMUTH, MARKUS; ZHOU, WENLAI; ZHU, PING
To: NOVARTIS AG
Reel/Frame 035690/0351 →
Assignment of Assignor's Interest May 21, 2015
From: ALNYLAM PHARMACEUTICALS, INC.
To: NOVARTIS AG
Reel/Frame 035690/0627 →
Security Interest Aug 7, 2024
From: ARROWHEAD PHARMACEUTICALS, INC.
To: SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT
Reel/Frame 068510/0363 →
Change of Name Aug 9, 2024
From: ARROWHEAD RESEARCH CORPORATION
To: ARROWHEAD PHARMACEUTICALS, INC.
Reel/Frame 068535/0926 →
Change of Name Aug 9, 2024
From: ARROWHEAD RESEARCH CORPORATION
To: ARROWHEAD PHARMACEUTICALS, INC.
Reel/Frame 068535/0872 →
Change of Name Aug 9, 2024
From: ARROWHEAD RESEARCH CORPORATION
To: ARROWHEAD PHARMACEUTICALS, INC.
Reel/Frame 068535/0805 →
Change of Name Aug 9, 2024
From: ARROWHEAD RESEARCH CORPORATION
To: ARROWHEAD PHARMACEUTICALS, INC.
Reel/Frame 068535/0627 →